Skip to main content
. Author manuscript; available in PMC: 2008 Feb 7.
Published in final edited form as: J Biomol Screen. 2007 Apr 13;12(4):521–535. doi: 10.1177/1087057107300463

FIG. 10.

FIG. 10

Dose response in the fluorescence polarization (FP) binding assay of selected compounds representative of each scaffold, compared to the reference inhibitor actinonin. The IC50s for each compound were hematoxylin, 2.7 μM; theaflavin, 6.1 μM; actinonin, 5.5 μM; and purpurogallin, 8.8 μM.